{
    "2019-12-06": [
        [
            {
                "time": "2018-12-06",
                "original_text": "公告精选：华兴源创拟11.5亿收购欧立通100%股权；多家车企披露销售数据",
                "features": {
                    "keywords": [
                        "华兴源创",
                        "收购",
                        "欧立通",
                        "车企",
                        "销售数据"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "科技",
                        "汽车"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-06",
                "original_text": "晚间公告热点追踪：阿里成美年健康第一大股东",
                "features": {
                    "keywords": [
                        "阿里",
                        "美年健康",
                        "第一大股东"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗健康"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-06",
                "original_text": "公告汇总：立华股份11月肉鸡销售同比增长52.04%",
                "features": {
                    "keywords": [
                        "立华股份",
                        "肉鸡",
                        "销售增长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "农业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-06",
                "original_text": "大秦铁路(601006)：高分红公共事业股，是否值得布局？",
                "features": {
                    "keywords": [
                        "大秦铁路",
                        "高分红",
                        "公共事业"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "交通运输"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-12-06",
                "original_text": "恒瑞医药：4名董监高拟合计减持不超62.6万股",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "减持",
                        "董监高"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-12-06",
                "original_text": "恒瑞医药：SHR6390临床试验获批用于治疗晚期乳腺癌",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "SHR6390",
                        "临床试验",
                        "乳腺癌"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-06",
                "original_text": "北向资金还在加仓！消费股龙头全面复苏？",
                "features": {
                    "keywords": [
                        "北向资金",
                        "加仓",
                        "消费股"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "消费"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-06",
                "original_text": "增强指数基金大盘点，定投仍大有可为？",
                "features": {
                    "keywords": [
                        "增强指数基金",
                        "定投"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-12-09",
                "original_text": "[民生医药|周报]：集采政策加快推进，稳妥加仓优势赛道",
                "features": {
                    "keywords": [
                        "民生医药",
                        "集采政策",
                        "加仓",
                        "优势赛道"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-06",
                "original_text": "广州万隆：泼水降温！A股还有两大难点未解",
                "features": {
                    "keywords": [
                        "广州万隆",
                        "泼水降温",
                        "A股",
                        "难点"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "市场整体"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}